Our Insights

Spotlight on oncology: Increasing access to patient-centered cancer care

As the global burden of disease shifts from infectious to chronic, non-communicable diseases, health systems and industry are tackling these challenges by focusing on how to provide personalized, patient-centered care to all people who need it, while considering issues around cost and value of innovation. Having just returned from the World Cancer Congress in ...

13 November 2018 read more

A useful new platform illustrates countries’ health security capacity

The Private Sector Roundtable (PSRT), of which Rabin Martin is the Secretariat, has been working with one of its members, Qlik, to develop and launch an online platform illustrating country qualitative and quantitative data on health security capacity. The platform is an interactive visualization of the data from the Joint External Evaluation (JEE), a ...

25 October 2018 read more

Reflections on the 73rd United Nations General Assembly

While newspaper headlines around the recent United Nations General Assembly were dominated by global policy and diplomacy narratives, representatives from the health sector working in government, NGOs, academe, civil society and the private sector were busy coming together around shared interests to address the world’s greatest health challenges. Two highly anticipated events included the ...

16 October 2018 read more

High-level meetings on TB and NCDs to follow this year’s United Nations General Assembly

This week, heads of state and members from civil society, development and the private sector will gather in New York for the United Nations General Assembly and related meetings. The formal agenda kicks off on September 18th, with the majority of side events that present a unique opportunity for multisectoral engagement and dialogue on key global health issues taking place September 23rd-27th.
17 September 2018 read more

Spotlight on corporate responsibility: Rabin Martin brings unique perspective to strengthen clients’ leadership in global health

Rabin Martin is proud to be a part of the Omnicom family, a company that is committed to promoting responsible practices and making positive contributions to society around the globe.  Our work was recently featured in Omnicom’s 2017 Corporate Responsibility report, showcasing how we work at the intersection of the private sector and unmet public health need to help our clients become leaders in health.
13 September 2018 read more

The power of partnerships: Rabin Martin showcases client work in global health

Rabin Martin is proud to highlight the multi-faceted work we do for our clients through two global health reports that we recently developed. These reports are strong examples of how Rabin Martin helps our clients derive value from their global health investments and showcase their important work in advancing the global health field through both research and evaluation and public/private partnerships.
08 August 2018 read more

Difficult but necessary: Sustaining progress for pediatric and adolescent HIV

Sustainability is a loaded word. Drop it into conversation with anyone involved in global health programming, policy, or funding, and you’re likely to get a reaction. For many, it conjures up a distant future state requiring endless funding and unwavering attention. For others, it is the holy grail of international health and development...
20 June 2018 read more

Diseases do not respect borders: A conversation with the CDC’s Dr. Rebecca Martin on the economic case for preventing disease outbreaks

Dr. Rebecca Martin is a fixture in the global health community. As director of the CDC’s Center for Global Health, Dr. Martin’s leadership has been a driving force in engaging the public and private sectors to accelerate progress towards disease prevention, detection and response around the world. Dr. Martin and her colleagues at the CDC are also important partners to the Global Health Security Agenda (GHSA) Private Sector Roundtable (PSRT), a coalition of companies that acts as a central touchpoint for industry to mobilize efforts to protect against, detect and respond to disease threats.
30 April 2018 read more